NASDAQ:XAIR Beyond Air (XAIR) Stock Price, News & Analysis $0.40 0.00 (-0.25%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$0.40 0.00 (0.00%) As of 05/22/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Beyond Air Stock (NASDAQ:XAIR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Beyond Air alerts:Sign Up Key Stats Today's Range$0.40▼$0.4450-Day Range$0.40▼$0.8352-Week Range$0.38▼$5.84Volume258,589 shsAverage Volume256,494 shsMarket Capitalization$5.29 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingHold Company Overview Beyond Air, Inc. is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine. The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity. Beyond Air is also evaluating LungFit® PT for pulmonary tuberculosis and LungFit® C for viral and bacterial lung infections, including potential applications in acute respiratory distress syndrome. These programs position the LungFit platform as a versatile therapy that may complement or improve upon existing treatment options. Beyond Air operates primarily in the United States and collaborates with academic and clinical research centers to advance its clinical trials. The company engages with regulatory authorities, including the U.S. Food and Drug Administration, to pursue marketing approvals and expanded indications for its nitric oxide therapies. By building strategic partnerships, Beyond Air aims to broaden access to its platform technology across diverse healthcare markets. Founded in 2013 and headquartered in East Setauket, New York, Beyond Air is led by President and Chief Executive Officer Nicholas E. Caputo, a life sciences executive with extensive experience in medical device development and regulatory strategy. Under his leadership, the company has advanced multiple product candidates through early-stage clinical evaluation and continues to build a pipeline of inhaled gas therapies designed to improve outcomes for patients with challenging respiratory conditions.AI Generated. May Contain Errors. Read More Beyond Air Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreXAIR MarketRank™: Beyond Air scored higher than 47% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingBeyond Air has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialBeyond Air has a consensus price target of $10.00, representing about 2,393.8% upside from its current price of $0.40.Amount of Analyst CoverageBeyond Air has only been the subject of 2 research reports in the past 90 days.Read more about Beyond Air's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Beyond Air is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Beyond Air is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBeyond Air has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Beyond Air's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.05% of the float of Beyond Air has been sold short.Short Interest Ratio / Days to CoverBeyond Air has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Beyond Air has recently increased by 88.59%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBeyond Air does not currently pay a dividend.Dividend GrowthBeyond Air does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A Search Interest4 people have searched for XAIR on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows3 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Beyond Air insiders have not sold or bought any company stock.Percentage Held by Insiders9.99% of the stock of Beyond Air is held by insiders.Percentage Held by Institutions31.50% of the stock of Beyond Air is held by institutions.Read more about Beyond Air's insider trading history. Receive XAIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XAIR Stock News HeadlinesBeyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026April 20, 2026 | globenewswire.comLucid, Beyond Air, Conagra stocks hit 52-week lows: What's behind the drag?April 16, 2026 | msn.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.May 24 at 1:00 AM | Porter & Company (Ad)Beyond Air Appeals Nasdaq Notice on Listing ComplianceApril 15, 2026 | tipranks.comBeyond Air to Participate in the D. Boral Capital Global Conference 2026April 15, 2026 | globenewswire.comBeyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)April 1, 2026 | markets.businessinsider.comBeyond Air Names Robert Goodman as New CEOApril 1, 2026 | tipranks.comBeyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEOMarch 26, 2026 | markets.businessinsider.comSee More Headlines XAIR Stock Analysis - Frequently Asked Questions How have XAIR shares performed this year? Beyond Air's stock was trading at $0.7260 at the beginning of the year. Since then, XAIR stock has decreased by 44.8% and is now trading at $0.4010. How were Beyond Air's earnings last quarter? Beyond Air, Inc. (NASDAQ:XAIR) issued its quarterly earnings data on Friday, February, 13th. The company reported ($0.85) earnings per share for the quarter, missing the consensus estimate of ($0.54) by $0.31. The business had revenue of $2.19 million for the quarter, compared to the consensus estimate of $2.15 million. Beyond Air had a negative trailing twelve-month return on equity of 268.82% and a negative net margin of 447.75%. Read the conference call transcript. When did Beyond Air's stock split? Shares of Beyond Air reverse split on the morning of Monday, July 14th 2025.A 1-20 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, July 13th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Beyond Air IPO? Beyond Air (XAIR) raised $330,000 in an initial public offering on Tuesday, May 7th 2019. The company issued 1,320,000 shares at a price of $0.25 per share. How do I buy shares of Beyond Air? Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Beyond Air own? Based on aggregate information from My MarketBeat watchlists, some other companies that Beyond Air investors own include Pfizer (PFE), NVIDIA (NVDA), General Motors (GM), Meta Platforms (META), Corbus Pharmaceuticals (CRBP), Norwegian Cruise Line (NCLH) and OPKO Health (OPK). Company Calendar Last Earnings2/13/2026Today5/24/2026Next Earnings (Estimated)6/29/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 XAIR's financial health is in the Red zone, according to TradeSmith. XAIR has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMedical Equipment Current SymbolNASDAQ:XAIR CIK1641631 Webwww.beyondair.net Phone(516) 665-8200FaxN/AEmployees70Year Founded2011Price Target and Rating Average Price Target for Beyond Air$10.00 High Price Target$10.00 Low Price Target$10.00 Potential Upside/Downside+2,393.8%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($5.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$46.62 million Net Margins-447.75% Pretax Margin-462.57% Return on Equity-268.82% Return on Assets-98.49% Debt Debt-to-Equity Ratio2.65 Current Ratio5.12 Quick Ratio4.77 Sales & Book Value Annual Sales$3.70 million Price / Sales1.43 Cash FlowN/A Price / Cash FlowN/A Book Value$3.32 per share Price / Book0.12Miscellaneous Outstanding Shares13,190,000Free Float11,875,000Market Cap$5.29 million OptionableOptionable Beta0.30 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:XAIR) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beyond Air With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
